This inventor holds 1 USPTO granted patent. Top assignee: Merrell Pharmaceuticals, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovations of Stephen M. Sorensen
Introduction
Stephen M. Sorensen is an accomplished inventor based in Illkirch, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of xanthine derivatives. His work focuses on the adenosine A1 receptor antagonists, which have important implications for various medical applications.
Latest Patents
Stephen M. Sorensen holds a patent for "Xanthine derivatives as adenosine A1 receptor antagonists." This patent represents his innovative approach to addressing challenges in pharmacology and showcases his expertise in medicinal chemistry. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.
Career Highlights
Stephen is currently employed at Merrell Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research. His role at the company allows him to collaborate with other talented professionals in the industry, contributing to the development of new therapeutic solutions.
Collaborations
Throughout his career, Stephen has worked alongside notable colleagues, including Janice M. Hitchcock and Mark W. Dudley. These collaborations have enriched his research and fostered a dynamic environment for innovation.
Conclusion
Stephen M. Sorensen's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors in advancing medical science. His work on xanthine derivatives highlights the importance of innovation in developing new treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile